Association Between Exposure to Topical Tacrolimus or Pimecrolimus and Cancers

Abstract

Exposure to topical tacrolimus or pimecrolimus was not associated with an increase in the overall cancer rate. Use of topical tacrolimus may be associated with an increased risk of T-cell lymphoma.